GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SCL Science Inc (XKRX:246960) » Definitions » Additional Paid-In Capital

SCL Science (XKRX:246960) Additional Paid-In Capital : ₩47,370 Mil(As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is SCL Science Additional Paid-In Capital?


SCL Science's quarterly additional paid-in capital increased from Sep. 2023 (₩41,912 Mil) to Dec. 2023 (₩47,370 Mil) and increased from Dec. 2023 (₩47,370 Mil) to Mar. 2024 (₩47,370 Mil).

SCL Science's annual additional paid-in capital increased from Dec. 2021 (₩32,647 Mil) to Dec. 2022 (₩38,488 Mil) and increased from Dec. 2022 (₩38,488 Mil) to Dec. 2023 (₩47,370 Mil).

SCL Science Additional Paid-In Capital Historical Data

The historical data trend for SCL Science's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SCL Science Additional Paid-In Capital Chart

SCL Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30,451.78 30,451.78 32,646.60 38,487.69 47,370.46

SCL Science Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43,286.91 43,534.07 41,911.69 47,370.46 47,370.46

SCL Science Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

SCL Science Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of SCL Science's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

SCL Science (XKRX:246960) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SCL Science Inc (XKRX:246960) » Definitions » Additional Paid-In Capital
Comparable Companies
XKRX:419540 XKRX:238120 XKRX:058110 XKRX:115480 XKRX:200580 XKRX:335810 XKRX:402420 XKRX:311960 XKRX:043100 XKRX:337840 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
Seonyu-ro 13-gil, ACE Hitech City 2, 25, Number 1209, Yeongdeungpo-gu, Seoul, KOR, 07282
Website
http://www.innotherapy.com
InnoTherapy Inc is a South-Korea based medical device company. It has developed a technology to control physical property of bio-inspired by the adhesive properties of living organisms. The products offered by the company include InnoSEAL, EndoSil and GellySil among others.

SCL Science (XKRX:246960) Headlines

No Headlines